These results suggest that circZBTB46 and miRNA-326 exert opposing effects on intrahepatic lipid deposition by modulating the FGF1/AMPK signaling axis, thereby playing critical roles in the pathogenesis of MASLD. The gene discussed is FGF1; the disease is metabolic dysfunction-associated steatotic liver disease.